Meeting
2015 Gastrointestinal Cancers Symposium
Comparison of four models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma (HCC).
Authors
Zhan-Hong Chen
Department of Medical Oncology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, NV, China
Zhan-Hong Chen , Xiao-kun Ma , Xing Li , Yingfen Hong , Dong-hao Wu , Min Dong , Qu Lin , Xiang-yuan Wu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 251)
DOI
10.1200/jco.2015.33.3_suppl.251
Abstract #
251
Poster Bd #
A22
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A single-center, real-world experience of atezolizumab plus bevacizumab as first-line therapy in patients with unresectable hepatocellular carcinoma, including patients with advanced cirrhosis.
First Author: Jay Parekh
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Evaluating the safety and efficacy of the addition of liver radiation (RT) to atezolizumab and bevacizumab (A/B) in advanced hepatocellular carcinoma (HCC): A retrospective cohort analysis.
First Author: Timothy J. Brown
Poster
2023 ASCO Annual Meeting
Application of the albumin-bilirubin (ALBI) grade as predictive marker of atezolizumab plus bevacizumab (A+B) treatment outcomes for patients with advanced hepatocellular carcinoma (HCC): Real-world retrospective analysis at Veterans Health Administration (VHA).
First Author: Munaf Alkadimi
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Stereotactic body radiotherapy (SBRT) with functional treatment planning in patients with hepatocellular carcinoma (HCC) and advanced hepatic cirrhosis: Survival outcomes and toxicity.
First Author: Alexander V. Kirichenko